H3K9me2 regulates early transcription factors to promote mesenchymal stem‑cell differentiation into cardiomyocytes

Sun,Xiaolin; Gu,Xiang; Li,Hongxiao; Xu,Pei; Li,Mengting; Zhu,Ye; Zuo,Qisheng; Li,Bichun

doi:10.3892/mmr.2021.12255

H3K9me2 regulates early transcription factors to promote mesenchymal stem‑cell differentiation into cardiomyocytes

Authors:
- Xiaolin Sun
- Xiang Gu
- Hongxiao Li
- Pei Xu
- Mengting Li
- Ye Zhu
- Qisheng Zuo
- Bichun Li
View Affiliations

Affiliations: Department of Cardiology, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China, Department of Cardiology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu 225001, P.R. China, Department of Hematology, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China, Key Laboratory of Animal Breeding and Molecular Design for Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China
Published online on: June 29, 2021 https://doi.org/10.3892/mmr.2021.12255
Article Number: 616

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Studies have shown that histone H3 at lysine 9 (H3K9me2) is an important epigenetic modifier of embryonic development, cell reprogramming and cell differentiation, but its specific role in cardiomyocyte formation remains to be elucidated. The present study established a model of 5‑Azacytidine‑induced differentiation of rat bone mesenchymal stem cells (MSCs) into cardiomyocytes and, on this basis, investigated the dimethylation of H3K9me2 and its effect on cardiomyocyte formation by knockdown of H3K9me2 methylase, euchromatic histone‑lysine N‑methyltransferase 2 (G9a) and H3K9me2 lysine demethylase 3A (KDM3A). The results demonstrated that, in comparison with the normal induction process, the knockdown of G9a could significantly reduce the H3K9me2 level of the MSCs in the induced model. Reverse transcription‑quantitative (RT‑q) PCR demonstrated that the expression of cardiac troponin T(cTnT) was significantly increased. In addition, flow cytometry demonstrated that the proportion of cTnT‑positive cells was significantly increased on day 21. With the knockdown of KDM3A, the opposite occurred. In order to explore the specific way of H3K9me2 regulating cardiomyocyte formation, western blotting and RT‑qPCR were used to detect the expression of key transcription factors including GATA binding protein 4 (GATA‑4), NK2 Homeobox 5 (Nkx2.5) and myocyte enhancer factor 2c (MEF2c) during cardiomyocyte formation. The decrease of H3K9me2 increased the expression of transcription factors GATA‑4, Nkx2.5 and MEF2c in the early stage of myocardial development while the increase of H3K9me2 inhibited the expression of those transcription factors. Accordingly, it was concluded that H3K9me2 is a negative regulator of cardiomyocyte formation and can participate in cardiomyocyte formation by activating or inhibiting key transcription factors of cardiomyocytes, which will lay the foundation for the optimized induction efficiency of cardiomyocytes in in vitro and clinical applications.

View Figures

View References

1	Barstow C and McDivitt JD: Cardiovascular disease update: Bradyarrhythmias. FP Essent. 454:18–23. 2017.PubMed/NCBI
2	Burns CG and Burns CE: Canonical Wnt signaling sets the pace. Dev Cell. 50:675–676. 2019. View Article : Google Scholar : PubMed/NCBI
3	Bagno L, Hatzistergos KE, Balkan W and Hare JM: Mesenchymal stem cell-based therapy for cardiovascular disease: Progress and challenges. Mol Ther. 26:1610–1623. 2018. View Article : Google Scholar : PubMed/NCBI
4	Fukuda K: Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs. 25:187–193. 2001. View Article : Google Scholar : PubMed/NCBI
5	Hou J, Lü AL, Liu BW, Hou J, Xing YJ, Da J, Hou ZL and Ai SY: Combination of BMP-2 and 5-AZA is advantageous in rat bone marrow-derived mesenchymal stem cells differentiation into cardiomyocytes. Cell Biol Int. 37:1291–1299. 2013. View Article : Google Scholar : PubMed/NCBI
6	Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J, Zhou H and Chen Y: Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood). 229:623–631. 2004. View Article : Google Scholar : PubMed/NCBI
7	Cheng F, Zou P, Yang H, Yu Z and Zhong Z: Induced differentiation of human cord blood mesenchymal stem/progenitor cells into cardiomyocyte-like cell in vitro. J Huazhong Univ Sci Technolog Med Sci. 23:154–157. 2003. View Article : Google Scholar : PubMed/NCBI
8	Luo L, Tang J, Nishi K, Yan C, Dinh PU, Cores J, Kudo T, Zhang J, Li TS and Cheng K: Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in mice. Circ Res. 120:1768–1775. 2017. View Article : Google Scholar : PubMed/NCBI
9	Li J, Zhu K, Wang Y, Zheng J, Guo C, Lai H and Wang C: Combination of IGF1 gene manipulation and 5-AZA treatment promotes differentiation of mesenchymal stem cells into cardiomyocyte-like cells. Mol Med Rep. 11:815–820. 2015. View Article : Google Scholar : PubMed/NCBI
10	Saito Y, Nakamura K, Yoshida M, Sugiyama H, Takano M, Nagase S, Morita H, Kusano KF and Ito H: HCN4-overexpressing mouse embryonic stem cell-derived cardiomyocytes generate a new rapid rhythm in rats with bradycardia. Int Heart J. 59:601–606. 2018. View Article : Google Scholar : PubMed/NCBI
11	Gorabi AM, Hajighasemi S, Tafti HA, Atashi A, Soleimani M, Aghdami N, Saeid AK, Khori V, Panahi Y and Sahebkar A: TBX18 transcription factor overexpression in human-induced pluripotent stem cells increases their differentiation into pacemaker-like cells. J Cell Physiol. 234:1534–1546. 2019. View Article : Google Scholar : PubMed/NCBI
12	Yang G, Tian J, Feng C, Zhao LL, Liu Z and Zhu J: Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition. Cell Transplant. 21:985–996. 2012. View Article : Google Scholar : PubMed/NCBI
13	Singh PB, Belyakin SN and Laktionov PP: Biology and physics of heterochromatin-like domains/complexes. Cells. 9:18812020. View Article : Google Scholar : PubMed/NCBI
14	Yang J, Kaur K, Edwards JG, Eisenberg CA and Eisenberg LM: Inhibition of histone methyltransferase, histone deacetylase, and β-catenin synergistically enhance the cardiac potential of bone marrow cells. Stem Cells Int. 2017:34649532017. View Article : Google Scholar : PubMed/NCBI
15	Zhang QJ, Tran TAT, Wang M, Ranek MJ, Kokkonen-Simon KM, Gao J, Luo X, Tan W, Kyrychenko V, Liao L, et al: Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis. Nat Commun. 9:52302018. View Article : Google Scholar : PubMed/NCBI
16	Huang YL, Qiu RF, Mai WY, Kuang J, Cai XY, Dong YG, Hu YZ, Song YB, Cai AP and Jiang ZG: Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro. J Zhejiang Univ Sci B. 13:20–28. 2012. View Article : Google Scholar : PubMed/NCBI
17	Nippert F, Schreckenberg R and Schlüter KD: Isolation and cultivation of adult rat cardiomyocytes. J Vis Exp. 128:566342017.PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Sun X, Li H, Zhu Y, Xu P, Zuo Q, Li B and Gu X: 5-Azacytidine-induced cardiomyocyte differentiation of very small embryonic-like stem cells. Stem Cells Int. 2020:51623502020. View Article : Google Scholar : PubMed/NCBI
20	Thienpont B, Aronsen JM, Robinson EL, Okkenhaug H, Loche E, Ferrini A, Brien P, Alkass K, Tomasso A, Agrawal A, et al: The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy. J Clin Invest. 127:335–348. 2017. View Article : Google Scholar : PubMed/NCBI
21	Abou-ElNaga A, El-Chennawi F, Ibrahim Kamel S and Mutawa G: The potentiality of human umbilical cord isolated mesenchymal stem/stromal cells for cardiomyocyte generation. Stem Cells Cloning. 13:91–101. 2020.PubMed/NCBI
22	Soltani L, Rahmani HR, Daliri Joupari M, Ghaneialvar H, Mahdavi AH and Shamsara M: Ovine fetal mesenchymal stem cell differentiation to cardiomyocytes, effects of co-culture, role of small molecules; reversine and 5-azacytidine. Cell Biochem Funct. 34:250–261. 2016. View Article : Google Scholar : PubMed/NCBI
23	Jain M, Minocha E, ripathy NK, Singh N, Chaturvedi CP and Nityanand S: Comparison of the cardiomyogenic potency of human amniotic fluid and bone marrow mesenchymal stem cells. Int J Stem Cells. 12:449–456. 2019. View Article : Google Scholar : PubMed/NCBI
24	Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A and Papakonstantinou C: In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg. 6:593–597. 2007. View Article : Google Scholar : PubMed/NCBI
25	Larsen F, Gundersen G, Lopez R and Prydz H: CpG islands as gene markers in the human genome. Genomics. 13:1095–1107. 1992. View Article : Google Scholar : PubMed/NCBI
26	Ruan ZB, Zhu L, Yin YG and Chen GC: The mechanism underlying the differentiation of human umbilical cord-derived mesenchymal stem cells into myocardial cells induced by 5-azacytidine. Indian J Med Sci. 64:402–407. 2010. View Article : Google Scholar : PubMed/NCBI
27	Enright BP, Kubota C, Yang X and Tian XC: Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2′-deoxycytidine. Biol Reprod. 69:896–901. 2003. View Article : Google Scholar : PubMed/NCBI
28	Choi SC, Yoon J, Shim WJ, Ro YM and Lim DS: 5-Azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med. 36:515–523. 2004. View Article : Google Scholar : PubMed/NCBI
29	Xu H, Yi Q, Yang C, Wang Y, Tian J and Zhu J: Histone modifications interact with DNA methylation at the GATA4 promoter during differentiation of mesenchymal stem cells into cardiomyocyte-like cells. Cell Prolif. 49:315–329. 2016. View Article : Google Scholar : PubMed/NCBI
30	Gilsbach R, Schwaderer M, Preissl S, Grüning BA, Kranzhöfer D, Schneider P, Nührenberg TG, Mulero-Navarro S, Weichenhan D, Braun C, et al: Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo. Nat Commun. 9:3912018. View Article : Google Scholar : PubMed/NCBI
31	Wang X, Wu H, Ma J, Xu S, Li S, Bao S and Wang F: threshold inhibition of methyltransferase G9a/Glp exacerbates neuropathic hypersensitivity through mediating GRIN2B methylation. Sci Insigt. 29:33–47. 2019. View Article : Google Scholar
32	Schones DE, Chen X, Trac C, Setten R and Paddison PJ: G9a/GLP-dependent H3K9me2 patterning alters chromatin structure at CpG islands in hematopoietic progenitors. Epigenetics Chromatin. 7:232014. View Article : Google Scholar : PubMed/NCBI
33	Liang L, Zhao JY, Kathryn T, Bekker A and Tao YX: BIX01294, a G9a inhibitor, alleviates nerve injury-induced pain hypersensitivities during both development and maintenance periods. Transl Perioper Pain Med. 6:106–114. 2019.PubMed/NCBI
34	Fu L, Yan FX, An XR and Hou J: Effects of the histone methyltransferase inhibitor UNC0638 on Histone H3K9 dimethylation of cultured ovine somatic cells and development of resulting early cloned embryos. Reprod Domest Anim. 49:e21–e25. 2014. View Article : Google Scholar : PubMed/NCBI
35	Qin L, Xu Y, Yu X, Toneff MJ, Li D, Liao L, Martinez JD, Li Y and Xu J: The histone demethylase Kdm3a is required for normal epithelial proliferation, ductal elongation and tumor growth in the mouse mammary gland. Oncotarget. 8:84761–84775. 2017. View Article : Google Scholar : PubMed/NCBI
36	Almalki SG and Agrawal DK: Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 92:41–51. 2016. View Article : Google Scholar : PubMed/NCBI
37	Cao F, Niu LL, Meng L, Zhao LX, Zheng M, Yue W, Bai CX, Jia GL and Pei XT: Cadiomyocyte-like differentiation of human bone marrow mesenchymal stem cells after exposure to 5-azacytidine in vitro. Shi Yan Sheng Wu Xue Bao. 37:118–124. 2004.PubMed/NCBI
38	Dong W, Oya E, Zahedi Y, Prasad P, Svensson JP, Lennartsson A, Ekwall K and Durand-Dubief M: Abo1 is required for the H3K9me2 to H3K9me3 transition in heterochromatin. Sci Rep. 10:60552020. View Article : Google Scholar : PubMed/NCBI